Showing results (11-20 of 658) with videos related to
Sort By:
Pageof 66
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2002
Markers of viral infection in monozygotic twins discordant for chronic fatigue syndromeDavid M Koelle, Serge Barcy, Meei-Li Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodesJoshua T Schiffer, Laith Abu-Raddad, Karen E Mark, et al.Methods (San Diego, Calif.)|May 3, 2003
Expression cloning for the discovery of viral antigens and epitopes recognized by T cellsDavid M KoelleCurrent Opinion in Investigational Drugs (London, England : 2000)|February 28, 2006
Vaccines for herpes simplex virus infectionsDavid M KoelleJournal of Virology|June 5, 2015
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensSita Awasthi, Gregory G Mahairas, Carolyn E Shaw, et al.Journal of Virology|May 16, 2006
Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpesNancy Hosken, Patrick McGowan, Amalia Meier, et al.Clinical and Vaccine Immunology : CVI|September 12, 2008
Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection systemAshok Cattamanchi, Christine M Posavad, Anna Wald, et al.Nature Medicine|August 4, 2009
Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisitionJia Zhu, Florian Hladik, Amanda Woodward, et al.Lancet (London, England)|January 10, 2012
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trialsChristine Johnston, Misty Saracino, Steve Kuntz, et al.Current Eye Research|November 12, 2005
Prospects for developing an effective vaccine against ocular herpes simplex virus infectionDavid M Koelle, Homayon GhiasiPageof 66